未登录

J

Jelena M. Janjic

duquesne university

H指数:30

被引数:2,876

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

On-demand engineering of bimodal nanoimaging agents for monitoring inflammation using quality-by-design

基于质量设计理念的可按需设计的双模态纳米成像剂用于炎症监测

COLLOIDS AND SURFACES B-BIOINTERFACES

IF5.6

2026-06-010

PRE

Theranostic nanoemulsions suppress macrophage-mediated acute inflammation in rats

Theranostic nanoemulsions抑制大鼠巨噬细胞介导的急性炎症

JOURNAL OF NANOBIOTECHNOLOGY

IF12.6

2025-02-040

OA

Quality by Design (QbD)-Driven Development and Optimization of Tacrolimus-Loaded Microemulsion for the Treatment of Skin Inflammation

IF5.5

2024-11-210

OAAI

Injectable, reversibly thermoresponsive captopril-laden hydrogel for the local treatment of sensory loss in diabetic neuropathy

可注射的，可逆的热响应性卡托普利水凝胶，用于局部治疗糖尿病性神经病的感觉丧失

SCIENTIFIC REPORTS

IF3.9

2024-08-162

OAAI

Biomaterials for Protein Delivery: Opportunities and Challenges to Clinical Translation

IF3

2024-04-155

OAAI

A Reversibly Thermoresponsive, Theranostic Nanoemulgel for Tacrolimus Delivery to Activated Macrophages: Formulation and In Vitro Validation

IF5.5

2023-09-225

OAAI

Folate-conjugated near-infrared fluorescent perfluorocarbon nanoemulsions as theranostics for activated macrophage COX-2 inhibition

SCIENTIFIC REPORTS

IF3.9

2023-09-143

OAAI

Multiple Linear Regression Predictive Modeling of Colloidal and Fluorescence Stability of Theranostic Perfluorocarbon Nanoemulsions

IF5.5

2023-03-297

OAAI

Behavioral and inflammatory sex differences revealed by celecoxib nanotherapeutic treatment of peripheral neuroinflammation

SCIENTIFIC REPORTS

IF3.9

2022-05-3012

OAAI

Sex differences in behavior and immune response revealed by a NSAID nanotherapeutic treatment during peripheral neuroinflammation

IF4.2

2022-05-131

PRE

Synthesis and Optimization of Nitroxide-Based Inhibitors of Ferroptotic Cell Death in Cancer Cells and Macrophages

ACS MEDICINAL CHEMISTRY LETTERS

IF4

2022-02-044

OA

Targeting Neuroimmune Interactions in Diabetic Neuropathy with Nanomedicine

用纳米药物靶向糖尿病神经病变的神经免疫相互作用

ANTIOXIDANTS & REDOX SIGNALING

IF6.1

2022-01-016

OA

Tracking macrophages in diabetic neuropathy with two-color nanoemulsions for near-infrared fluorescent imaging and microscopy

JOURNAL OF NEUROINFLAMMATION

IF10.1

2021-12-2311

OAAI

Quality by Design Methodology Applied to Process Optimization and Scale up of Curcumin Nanoemulsions Produced by Catastrophic Phase Inversion

IF5.5

2021-06-1512

OAAI

Quality by design approach identifies critical parameters driving oxygen delivery performance in vitro for perfluorocarbon based artificial oxygen carriers

SCIENTIFIC REPORTS

IF3.9

2021-03-1024

OAAI

Design of Thermoresponsive Polyamine Cross-Linked Perfluoropolyether Hydrogels for Imaging and Delivery Applications

ACS MEDICINAL CHEMISTRY LETTERS

IF4

2020-08-1110

OAAI

Sex Differences Revealed in a Mouse CFA Inflammation Model with Macrophage Targeted Nanotheranostics

IF13.3

2020-01-0136

OAAI

Nanomedicine-driven neuropathic pain relief in a rat model is associated with macrophage polarity and mast cell activation

ACTA NEUROPATHOLOGICA COMMUNICATIONS

IF5.7

2019-07-0532

OAAI

Quality by Design Approach Using Multiple Linear and Logistic Regression Modeling Enables Microemulsion Scale Up

IF4.6

2019-05-3013

OAAI

Dual Targeted Theranostic Nanomedicines for Local and Systemic Non-Opioid Analgesia in Trauma

JOURNAL OF PAIN

IF4

2019-04-010

OAAI